On the other hand, the estrogens/ERα signaling has been shown to skew the polarization of macrophages towards an immune-suppressive state, leading to sex-specific differences in response to immune checkpoint inhibitors (ICIs) in melanoma (9). This evidence concerns the gene ESR1 and melanoma.